Perimenopause Anxiety Symptoms
Anxiety disorders are different from having occasional worries or fears. When you are experiencing an anxiety disorder, the anxiety does not go away and sometimes it continues to grow and keeps getting worse over time. Abnormal anxiety will interfere with daily activities, making work, relationships, and normal functioning difficult. [3]
Symptoms associated with anxiety are commonly felt in the chest or abdomen, and include:
Anxiety disorders are different from having occasional worries or fears. When you are experiencing an anxiety disorder, the anxiety does not go away and sometimes it continues to grow and keeps getting worse over time. Abnormal anxiety will interfere with daily activities, making work, relationships, and normal functioning difficult. [3]
There are five major types of anxiety disorders:
Self-care for anxiety starts with compassion and kindness for yourself. Anxiety is awful and you do not deserve it, nor did you ‘ask’ for it. It can just happen, regardless of whether it seems rational. There are things that you can do, however, to help make it through this challenging symptom.
The good news is that anxiety can be helped. If you have had or are having anxiety, please ensure you have professional therapeutic care heading into perimenopause. At age 40 find a reliable, educated primary care provider familiar with recognizing and treating symptoms of perimenopause and menopause. The North American Menopause Society provides a list of menopause practitioners here.
Anxiety in women is very common across all ages starting in adolescence. The Women’s Preventive Services Initiative (WPSI), a national coalition of women’s health professional organizations and patient representatives in the US recommends screening for anxiety in women and adolescent girls aged 13 years or older who are not currently diagnosed with anxiety disorders, including pregnant and postpartum women. [13] Medications or therapy, either combined or separately, are the typical treatments for anxiety. [8]
Hormones and neurotransmitters are both chemical signaling molecules produced in our bodies. The primary difference between hormones and neurotransmitters is that hormones are produced in endocrine glands and are released into the bloodstream where they travel away from their place of origin to act on a target.
Neurotransmitters, on the other hand, enable nerve impulses to travel between neurons, or nerve cells.
Neurons are the basic unit of the brain and nervous system, and they are responsible for sending and receiving signals from your brain throughout your body. For example, when neurons receive the sensory input of heat from cells in your hand, they transmit that information to the brain. Your brain, in turn, sends a signal back down through your neurons to the muscles in your arm, causing you to pull your hand away from the hot stove.
Nerve signals, like the ones in the diagram to the left, are passed from the sending neuron via neurotransmitters (A) that bridge the gap between neurons where they attach to receptors in the receiving neuron (B). When the neurotransmitter lands in the neural receptor on the receiving neuron, the nerve signal has been transmitted (C). The neurotransmitter is released from the receptor back into the gap where it will be broken down and destroyed by enzymes. Alternatively, it can be returned back into the sending neuron where it will be reused or it will be broken down into its component parts until they are needed again (D). Nerve signals travel this way through millions of nerve cells until the signal reaches its destination. There are about 60 km (or 37 miles) of nerve cells stretched end to end throughout the human body!
Depression and anxiety are closely linked to the neurotransmitter molecule serotonin, which is nicknamed the ‘happiness molecule’ because it promotes feelings of well-being. While serotonin is a neurotransmitter, it can also function like a hormone, allowing it to have effects outside of the central nervous system. For example, serotonin has been shown to help with, among others, regulating appetite and temperature, maintaining energy balance, bone remodeling, and sleep cycles. [13]
Serotonin communicates with other molecules in order to perform its many roles, so hormones, particularly the female hormone estradiol (a form of estrogen), play a very important role in managing serotonin signaling. [14] For example, estradiol has been shown to be involved in, although not necessarily causing, pain transmission, headaches, dizziness, nausea, and depression, all of which occur as a result of some level of serotonin activity. [2] As well, estrogen increases serotonin receptor density in select brain regions including the hypothalamus. [1] In fact, estradiol directly modulates just about everything about serotonin biology (see the diagram below), so anxiety and low estrogen commonly go together. Ways in which estradiol impacts serotonin include:
During the menopausal transition, when estradiol levels start to drop, the levels of the enzyme tryptophan hydroxylase drops. This enzyme is the first ingredient needed to make serotonin, so when it becomes less available, less serotonin is being produced. In addition, serotonin production is further reduced because the expression of a different enzyme, monoamine oxidase, is no longer suppressed. This means that any free available serotonin is targeted by this enzyme and as a result, it gets rapidly broken down and becomes inactive. [6]
Neurobiologically, both vasomotor symptoms and depression are partially regulated by neurotransmitters, including serotonin. When these neurotransmitter systems become imbalanced and stop functioning properly, it can lead to depression if the imbalance occurs inside neural circuits (located in the brain) that are involved in mood regulation. However, when the imbalance occurs within the neural circuits involved in thermoregulation (temperature control) it can lead to vasomotor symptoms . [6]
Low serotonin levels add to menopausal transition symptoms such as insomnia, hot flashes, depression and brain fog. Because of this, some women’s symptoms will be helped by taking Selective Serotonin Reuptake Inhibitors (SSRIs), which are a type of antidepressant. SSRIs can work for menopausal transition symptoms because they block serotonin from being recycled back into the sending neuron – a process called reuptake. This results in having more serotonin available to transmit nerve signals from neuron to neuron. Having more serotonin working helps lessen the severity of hot flashes or mood swings because the lower the serotonin levels, the stronger the symptoms. [6]
MYTH
It is true that antidepressants are used as a long-term treatment option for some people diagnosed with anxiety. Psychotherapy, which is often prescribed along with antidepressants, can help you learn strategies to cope with any anxiety you are facing. As you get more skilled at coping, it is possible to wean yourself off of antidepressants used for treating anxiety.
MYTH
Anxiety is a real and serious medical condition. It is not a choice, nor is it a sign of weakness. It will not be resolved by thinking calm, relaxed thoughts alone. Changing your attitude can be helpful as part of a suite of interventions, but on its own, it is unlikely to resolve anxiety in the long-term. It is KEY to seek professional help.
YES
In time the anxiety will go away on its own, although you may continue to experience bouts of anxiety if you have worries in your life. Menopause anxiety is caused by the changes in your hormone levels as you enter into the menopausal transition. When your hormone levels stabilize after reaching menopause (when you haven’t had a period for one full year / 12 months) your anxiety should also stabilize and go away.
Anxiety is unpleasant regardless of why it starts. Anxiety is characterized by feelings of worry, feeling restless and on-edge, having difficulty focusing, and being irritable. It is also common to have insomnia, feel physically tense, and experience fatigue. Anxiety that starts during the menopausal transition is usually generalized anxiety, and you will feel chronic anxiety, worry and tension, even when there is no cause for anxiety and nothing is wrong. If you are already experiencing an anxiety disorder, such as social anxiety or obsessive compulsive disorder, your symptoms may get worse. See your healthcare provider to find the best treatment(s) to manage your anxiety.
Anxiety is anxiety, regardless of whether menopause triggers it, so symptoms of menopause anxiety are the same as those felt with non-menopause anxiety. Symptoms associated with anxiety are commonly felt in the chest or abdomen, and include:
Anxiety that starts during the menopausal transition will typically resolve itself once your hormones stabilize as you enter menopause. It is still important to seek help if your anxiety is strong because anxiety is treatable. There is no need to suffer for the length of your menopausal transition.
MYTH
Stress is part of life and can be very hard, if not impossible, to avoid. It is important to seek out help to learn effective coping strategies for stressful situations. This is especially important if you are aware that certain situations (like interpersonal conflict) can trigger your anxiety. Finding coping strategies that work is possible and using them successfully can have broader positive impacts as you successfully manage stressful situations.
YES
Anxiety is not just feeling worried and it is not a character flaw. They are complex disorders that have social, psychological and biological causes. Do not think that you can just think them away, or that they are normal. Help is available so talk to your healthcare provider. While sadness, stress, anxiety, and worry are normal and common, when they occur frequently and/or in intense episodes, this is a real and serious medical problem.
[1] Jaeger MB, Miná CS, Alves S, Schuh GJ, Wender MC, Manfro GG. Negative affect symptoms, anxiety sensitivity, and vasomotor symptoms during perimenopause. Braz J Psychiatry. 2021 May-Jun;43(3):277-284. doi: 10.1590/1516-4446-2020-0871. PMID: 33053044; PMCID: PMC8136388.
[2] https://www.nimh.nih.gov/health/topics/anxiety-disorders
[3] https://www.nimh.nih.gov/health/topics/anxiety-disorders
[3a] Mathis MA, Alvarenga Pd, Funaro G, Torresan RC, Moraes I, Torres AR, Zilberman ML, Hounie AG. Gender differences in obsessive-compulsive disorder: a literature review. Braz J Psychiatry. 2011 Dec;33(4):390-9. doi: 10.1590/s1516-44462011000400014. PMID: 22189930.
[5] American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). https://doi.org/10.1176/appi.books.9780890425596
[6] https://adaa.org/sites/default/files/GAD-7_Anxiety-updated_0.pdf
[7] https://www.medicalnewstoday.com/articles/317552#anxiety-and-menopause
[8] https://www.menopause.org/for-women/menopauseflashes/menopause-symptoms-and-treatments/going-mad-in-perimenopause-signs-and-solutions
[9] Thurston RC, Joffe H. Vasomotor symptoms and menopause: findings from the Study of Women’s Health across the Nation. Obstet Gynecol Clin North Am. 2011 Sep;38(3):489-501. doi: 10.1016/j.ogc.2011.05.006. PMID: 21961716; PMCID: PMC3185243.
[10] Gorman JM. Comorbid depression and anxiety spectrum disorders. Depress Anxiety. 1996-1997;4(4):160-8. doi: 10.1002/(SICI)1520-6394(1996)4:4<160::AID-DA2>3.0.CO;2-J. PMID: 9166648.
[11] Masakazu Terauchi,Shiro Hiramitsu, Mihoko Akiyoshi Yoko Owa, Kiyoko Kato
Satoshi Obayashi,Eisuke Matsushima,Toshiro Kubota (2012) Associations between anxiety, depression and insomnia in peri- and post-menopausal women. Maturitas Volume 72, Issue 1, pg 61-65.:https://doi.org/10.1016/j.maturitas.2012.01.014
[13] https://www.womenspreventivehealth.org/recommendations/screening-for-anxiety/
[13a] https://www.healthline.com/health/cbt-techniques
[14] https://www.nimh.nih.gov/health/topics/anxiety-disorders#part_2225
[15] https://www.zrtlab.com/blog/archive/impact-hormones-serotonin-depression/#_edn12
[16] Rybaczyk LA, Bashaw MJ, Pathak DR, Moody SM, Gilders RM, Holzschu DL. An overlooked connection: serotonergic mediation of estrogen-related physiology and pathology. BMC Womens Health. 2005;5:12. Published 2005 Dec 20. doi:10.1186/1472-6874-5-12
[17] Parry, Barbara L. MD Towards improving recognition and management of perimenopausal depression, Menopause: April 2020 – Volume 27 – Issue 4 – p 377-379
doi: 10.1097/GME.0000000000001519
[18] Maki, Pauline M. PhD1; Freeman, Ellen W. PhD2; Greendale, Gail A. MD3; Henderson, Victor W. MD, MS4; Newhouse, Paul A. MD5; Schmidt, Peter J. MD6; Scott, Nelda F. MD7; Shively, Carol A. PhD8; Soares, Claudio N. MD, PhD, FRCP9 Summary of the National Institute on Aging-sponsored conference on depressive symptoms and cognitive complaints in the menopausal transition, Menopause: July 2010 – Volume 17 – Issue 4 – p 815-822
doi: 10.1097/gme.0b013e3181d763d2
[19] https://www.zrtlab.com/blog/archive/mood-menopause-perimenopause
[20] Wise, D., Felker, A., & Stahl, S. (2008). Tailoring Treatment of Depression for Women Across the Reproductive Lifecycle: The Importance of Pregnancy, Vasomotor Symptoms, and Other Estrogen-Related Events in Psychopharmacology. CNS Spectrums, 13(8), 647-662. doi:10.1017/S1092852900013742
Original content, last updated February 22, 2023.
© 2024 Herstasis® Health Foundation